Literature DB >> 22759384

Comparison of the long-term outcomes of kidney transplantation: USA versus Spain.

Akinlolu O Ojo1, José María Morales, Miguel González-Molina, Diane E Steffick, Fu L Luan, Robert M Merion, Tammy Ojo, Francesc Moreso, Manuel Arias, Josep María Campistol, Domingo Hernandez, Daniel Serón.   

Abstract

BACKGROUND: The long-term outcomes of kidney transplantation are suboptimal because many patients lose their allografts or experience premature death. Cross-country comparisons of long-term outcomes of kidney transplantation may provide insight into factors contributing to premature graft failure and death. We evaluated the rates of late graft failure and death among US and Spanish kidney recipients.
METHODS: This is a cohort study of US (n = 9609) and Spanish (n = 3808) patients who received a deceased donor kidney transplant in 1990, 1994, 1998 or 2002 and had a functioning allograft 1 year after transplantation with follow-up through September 2006. Ten-year overall and death-censored graft survival and 10-year overall recipient survival and death with graft function (DWGF) were estimated with multivariate Cox models.
RESULTS: Among recipients alive with graft function 1 year after transplant, the 10-year graft survival was 71.3% for Spanish and 53.4% for US recipients (P < 0.001). The 10-year, death-censored graft survival was 75.6 and 76.0% for Spanish and US recipients, respectively (P = 0.73). The 10-year recipient survival was 86.2% for Spanish and 67.4% for US recipients (P < 0.001). In recipients with diabetes as the cause of ESRD, the adjusted DWGF rates at 10 years were 23.9 and 53.8 per 1000 person-years for Spanish and US recipients, respectively (P < 0.001). Among recipients whose cause of ESRD was not diabetes mellitus, the adjusted 10-year DWGF rates were 11.0 and 25.4 per 1000 person-years for Spanish and US recipients, respectively.
CONCLUSIONS: US kidney transplant recipients had more than twice the long-term hazard of DWGF compared with Spanish kidney transplant recipients and similar levels of death-censored graft function. Pre-transplant medical care, comorbidities, such as cardiovascular disease, and their management in each country's health system are possible explanations for the differences between the two countries.

Entities:  

Mesh:

Year:  2012        PMID: 22759384      PMCID: PMC3616762          DOI: 10.1093/ndt/gfs287

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  26 in total

1.  1997 spanish nephrology association (Sociedad Española de nefrologia) report on dialysis and transplantation.

Authors:  J J Amenábar; F García-López; N R Robles; R Saracho; M Calero; M A Gentil; M J Aladren; E Martín-Martinez; J Bestard; J Marco; V Lorenzo; A L Martín De Francisco; T Sierra; A Rodrigo; M Clèries; E Vela; F Otero; A Sánchez-Casajús; M Rodríguez-Gironés; C Solozábal; A Magaz; M J García-Blasco; O Zurriaga; I Zamora; A Vallo
Journal:  Nephrol Dial Transplant       Date:  1999-12       Impact factor: 5.992

2.  [Dialysis and transplantation report of the Spanish Nephrology Society and Autonomous Registries for the year 2000].

Authors:  J J Amenábar; F García López; N R Robles; R Saracho; J Pinilla; M A Gentil; J Castilla; J A Gutiérrez; E Martín-Martínez; R Alonso; R Bernabéu; V Lorenzo; N Vega; R Escallada; T Sierra; M Clèries; E Vela; S Tallón; B Cancho; C Vázquez; A Sánchez-Casajús; A Torralbo; J Ripoll; J L Asín; A Magaz; M J García; O Zurriaga
Journal:  Nefrologia       Date:  2002       Impact factor: 2.033

3.  Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant.

Authors:  R A Wolfe; V B Ashby; E L Milford; A O Ojo; R E Ettenger; L Y Agodoa; P J Held; F K Port
Journal:  N Engl J Med       Date:  1999-12-02       Impact factor: 91.245

4.  Long-term management of the renal transplant recipient: optimizing the relationship between the transplant center and the community nephrologist.

Authors:  A D Howard
Journal:  Am J Kidney Dis       Date:  2001-12       Impact factor: 8.860

5.  Vascular access use in Europe and the United States: results from the DOPPS.

Authors:  Ronald L Pisoni; Eric W Young; Dawn M Dykstra; Roger N Greenwood; Erwin Hecking; Brenda Gillespie; Robert A Wolfe; David A Goodkin; Philip J Held
Journal:  Kidney Int       Date:  2002-01       Impact factor: 10.612

6.  Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation.

Authors:  B L Kasiske; M A Vazquez; W E Harmon; R S Brown; G M Danovitch; R S Gaston; D Roth; J D Scandling; G G Singer
Journal:  J Am Soc Nephrol       Date:  2000-10       Impact factor: 10.121

7.  Payment for immunosuppression after organ transplantation. American Society of Transplantation.

Authors:  B L Kasiske; D Cohen; M R Lucey; J F Neylan
Journal:  JAMA       Date:  2000-05-10       Impact factor: 56.272

8.  Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Authors:  David A Goodkin; Jennifer L Bragg-Gresham; Karl G Koenig; Robert A Wolfe; Takashi Akiba; Vittorio E Andreucci; Akira Saito; Hugh C Rayner; Kiyoshi Kurokawa; Friedrich K Port; Philip J Held; Eric W Young
Journal:  J Am Soc Nephrol       Date:  2003-12       Impact factor: 10.121

9.  Who is caring for kidney transplant patients? Variation by region, transplant center, and patient characteristics.

Authors:  Ajay K Israni; Jon J Snyder; Melissa A Skeans; Anne V Tuomari; J Ross Maclean; Bertram L Kasiske
Journal:  Am J Nephrol       Date:  2009-09-15       Impact factor: 3.754

Review 10.  Patterns of care for patients with chronic kidney disease in the United States: dying for improvement.

Authors:  William F Owen
Journal:  J Am Soc Nephrol       Date:  2003-07       Impact factor: 10.121

View more
  26 in total

1.  Toward Establishing Core Outcome Domains For Trials in Kidney Transplantation: Report of the Standardized Outcomes in Nephrology-Kidney Transplantation Consensus Workshops.

Authors:  Allison Tong; John Gill; Klemens Budde; Lorna Marson; Peter P Reese; David Rosenbloom; Lionel Rostaing; Germaine Wong; Michelle A Josephson; Timothy L Pruett; Anthony N Warrens; Jonathan C Craig; Benedicte Sautenet; Nicole Evangelidis; Angelique F Ralph; Camilla S Hanson; Jenny I Shen; Kirsten Howard; Klemens Meyer; Ronald D Perrone; Daniel E Weiner; Samuel Fung; Maggie K M Ma; Caren Rose; Jessica Ryan; Ling-Xin Chen; Martin Howell; Nicholas Larkins; Siah Kim; Sobhana Thangaraju; Angela Ju; Jeremy R Chapman
Journal:  Transplantation       Date:  2017-08       Impact factor: 4.939

2.  Kidney transplantation in Romania: two transplant centers experience.

Authors:  A Gramaticu; D Siriopol; A Miron; D Tacu; I Sinescu; C Gingu; C Bucsa; A Nastasa; A Covic
Journal:  Int Urol Nephrol       Date:  2017-11-17       Impact factor: 2.370

3.  Different in vitro proliferation and cytokine-production inhibition of memory T-cell subsets after calcineurin and mammalian target of rapamycin inhibitors treatment.

Authors:  David Merino; David San Segundo; Juan M Medina; Emilio Rodrigo; Esther Asensio; Juan Irure; Gema Fernández-Fresnedo; Manuel A Arias; Marcos López-Hoyos
Journal:  Immunology       Date:  2016-03-29       Impact factor: 7.397

4.  Dialysis Vintage and Outcomes after Kidney Transplantation: A Retrospective Cohort Study.

Authors:  Maria C Haller; Alexander Kainz; Heather Baer; Rainer Oberbauer
Journal:  Clin J Am Soc Nephrol       Date:  2016-11-28       Impact factor: 8.237

5.  Non-immunologic allograft loss in pediatric kidney transplant recipients.

Authors:  Isa F Ashoor; Vikas R Dharnidharka
Journal:  Pediatr Nephrol       Date:  2018-02-26       Impact factor: 3.714

Review 6.  Vascular calcification, bone and mineral metabolism after kidney transplantation.

Authors:  Luis D'Marco; Antonio Bellasi; Sandro Mazzaferro; Paolo Raggi
Journal:  World J Transplant       Date:  2015-12-24

Review 7.  Vascular calcification: When should we interfere in chronic kidney disease patients and how?

Authors:  Usama Abdel Azim Sharaf El Din; Mona Mansour Salem; Dina Ossama Abdulazim
Journal:  World J Nephrol       Date:  2016-09-06

Review 8.  Current evidence on vitamin D deficiency and kidney transplant: What's new?

Authors:  Gerardo Sarno; Riccardo Nappi; Barbara Altieri; Giacomo Tirabassi; Emanuele Muscogiuri; Gianmaria Salvio; Stavroula A Paschou; Aristide Ferrara; Enrico Russo; Daniela Vicedomini; Cerbone Vincenzo; Andromachi Vryonidou; Silvia Della Casa; Giancarlo Balercia; Francesco Orio; Paride De Rosa
Journal:  Rev Endocr Metab Disord       Date:  2017-09       Impact factor: 6.514

9.  Impact of HLA Mismatching on Early Subclinical Inflammation in Low-Immunological-Risk Kidney Transplant Recipients.

Authors:  Domingo Hernández; Teresa Vázquez; Juana Alonso-Titos; Myriam León; Abelardo Caballero; María Angeles Cobo; Eugenia Sola; Verónica López; Pedro Ruiz-Esteban; Josep María Cruzado; Joana Sellarés; Francesc Moreso; Anna Manonelles; Alberto Torio; Mercedes Cabello; Juan Delgado-Burgos; Cristina Casas; Elena Gutiérrez; Cristina Jironda; Julia Kanter; Daniel Serón; Armando Torres
Journal:  J Clin Med       Date:  2021-04-29       Impact factor: 4.241

10.  Long-Term Progression of Coronary Artery Calcification Is Independent of Classical Risk Factors, C-Reactive Protein, and Parathyroid Hormone in Renal Transplant Patients.

Authors:  Sibel Gulcicek; Carmine Zoccali; Deniz Çebi Olgun; Giovanni Tripepi; Selma Alagoz; Serkan Feyyaz Yalın; Sinan Trabulus; Mehmet R Altiparmak; Nurhan Seyahi
Journal:  Cardiorenal Med       Date:  2017-07-13       Impact factor: 2.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.